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Background: The physiological roles of many ER 
quality control components are unknown. 
Results: Male Ube2j1-/- mice are sterile with 
defects in flagella and acrosome function, and 
cytoplasm removal in sperm cells.  
Conclusion: Spermatogenesis is a previously 
unknown process requiring ER quality control. 
Significance: ER quality control components 
might serve as diagnostic or therapeutic targets for 
male infertility in the future. 
    
ABSTRACT 
ER-resident proteins destined for degradation 
are dislocated into the cytosol by components of 
the ER quality control machinery for 
proteasomal degradation. Dislocation 
substrates are ubiquitylated in the cytosol by 
E2 ubiquitin conjugating/E3 ligase complexes. 
UBE2J1 is one of the well-characterized E2 
enzymes that participate in this process. 
However, the physiological function of Ube2j1 
is poorly defined. We find that Ube2j1-/- mice 
have reduced viability and fail to thrive early 
after birth. Male Ube2j1-/- mice are sterile due 
to a defect in late spermatogenesis. 
Ultrastructural analysis shows that removal of 
the cytoplasm is incomplete in Ube2j1-/- 
elongating spermatids, compromising the 
release of mature elongate spermatids into the 
lumen of the seminiferous tubule. Our findings 
identify an essential function for the ubiquitin-
proteasome-system in spermiogenesis and 
define a novel, non-redundant physiological 
function for the dislocation step of ER quality 
control. 
 
Components of the endoplasmic reticulum (ER) 
quality control system recognize proteins no 
longer wanted in the ER and target them for 
degradation. During this process, misfolded 
proteins are extracted from the ER (ER 
dislocation) and delivered to the cytosol for 
proteasomal degradation (1). Substrate dislocation 
is driven by concerted ubiquitylation and 
deubiquitylation reactions (2). Ubiquitylation 
involves the action of three enzymes, E1 ubiquitin-
activating enzymes, E2 ubiquitin-conjugating 
enzymes, and E3 ubiquitin ligases.  
E2 ubiquitin-conjugating enzymes known to be 
involved in ER dislocation include the yeast 
Ubc6p orthologs UBE2J1 (UBC6e, NCUBE1) and 
UBE2J2 (UBC6, NCUBE2) (3,4), tail-anchored 
proteins in the ER membrane with their catalytic 
domain facing the cytosol. UBE2J1 is part of the 
SEL1L dislocation complex, which contains 
several other factors known to be involved in ER 
dislocation. These include HRD1, Derlin-2, p97, 
PDI, BiP, Calnexin, AUP1, UBXD8 and OS9 (5). 
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In the absence of β2-microglobulin, the heavy 
chain of the human class I MHC molecule HLA-
B27 is ubiquitylated, dislocated and degraded by 
the concerted action of UBE2J1 and the E3 ligase 
HRD1 (Synoviolin) (5). In contradistinction, 
UBE2J1 cooperates with the E3 ligase RMA8 and 
with Derlin-1 in the degradation of CFTRΔ508 
(6). Moreover, UBE2J1 is involved in the 
degradation of other model substrates for ER 
dislocation, such as the unpaired TCRα chain, and 
class I MHC heavy chains in the presence of the 
HCMV-derived immunoevasin US11 (4,6).  
Despite accumulating data in tissue culture models 
on the function and mechanisms of ER dislocation, 
its physiological function in an organismal context 
is poorly defined, due to the limited number of 
model substrates and cell lines investigated and 
due to the lack of appropriate in vivo mammalian 
models. To obtain further insight into the 
physiological role of ER dislocation, we generated 
a floxed allele of Ube2j1 in mice and analyzed 
Ube2j1-/- mice.  
Although Ube2j1 has been repeatedly implicated 
in the dislocation of various misfolded 
glycoprotein substrates, mice that lack Ube2j1 are 
viable and show no gross aberrations in 
morphology or behavior. On the assumption that 
ER quality control is essential to development and 
survival, these results suggest remarkable 
redundancy in its mode of operation. The main 
defect we observe in Ube2j1-/- animals, 
surprisingly, is male sterility due to defects in 
flagella and acrosome function, and defective 
removal of cytoplasm from elongating spermatids. 
Our results thus identify a unique, non-redundant 
role for Ube2j1 in male germ cell development 
and define a previously unknown physiological 
function of ER dislocation.  
 
EXPERIMENTAL PROCEDURES 
Generation of Ube2j1fl/fl mice - We generated mice 
carrying a conditional allele of the gene encoding 
UBE2J1 (also known as UBC6e or NCUBE1, 
gene name Ube2j1) by homologous recombination 
(Fig. 1A). Genomic sequences were amplified by 
PCR from a BAC clone (Clone DB name RP24-
531A22; C57BL/6J, male, brain, spleen; BAC-
PAC Resources, Oakland, CA) containing the 
genomic sequence of Ube2j1 from C57BL/6J 
mice. Ube2j1 consists of 8 exons. We constructed 
a targeting vector based on the pPGKneoF2L2dta 
(‘pF2L2’, Addgene 13445, (7)) vector to install 
LoxP sites in introns 1 and 3, allowing conditional 
ablation of Ube2j1 in the presence of Cre 
recombinase. A neomycin resistance cassette 
flanked by FRT sites was inserted upstream of the 
3’ LoxP site between exon 3 and 4. The LoxP sites 
were flanked by a ~4.6 kb 5’ and a ~2.8 kb 3’ 
homology arm. The linearized targeting construct 
was electroporated into JM8A3.N1 ES cells (strain 
C57BL/6N, agouti; obtained from the KOMP 
Repository), which were subsequently grown in 
the presence of neomycin. ES cells were selected 
with 300 µg/mL G418 (Geneticin; Gibco, Life 
Technologies; Grand Island, NY) for six days. 
G418-resistant ES cell colonies were screened for 
correct targeting by Southern blotting or long 
range PCR, and correctly targeted ES cell clones 
were injected into C57BL/6J blastocysts. 
Chimeras were bred with FLPe transgenic mice 
(JAX strain B6.Cg-Tg(ACTFLPe)9205Dym/J; 
Jackson Laboratories, Bar Harbor, ME) to excise 
the neomycin resistance cassette. Ube2j1fl/WT mice 
were intercrossed to obtain FLPe- Ube2j1fl/WT 
mice. FLPe- Ube2j1fl/WT mice were then crossed to 
CMV-Cre transgenic mice (JAX strain B6.C-
Tg(CMV-cre)1Cgn/J; Jackson Laboratories, Bar 
Harbor, ME) to generate full-body knockout mice 
(Ube2j1-/-) and to CD19-Cre mice (JAX strain 
B6.129P2(C)-Cd19tm1(cre)Cgn/J; Jackson 
Laboratories, Bar Harbor, ME) for specific 
ablation in B cells (CD19-Cre Ube2j1fl/fl). 
Mice were genotyped by PCR using primers 
annealing to the genomic regions indicated in Fig. 
1A (A: 5’- GCCTCTGAGGATTTCCTGTGAGG-
3’; B: 5’- ATGGAGACCCGCTACAACCT-3’; C: 
5’- GCAGGATAATGCTTGGTGGTT-3’). The 
expected amplicon sizes are 458bp for the wild-
type, 531bp for the ‘floxed’, and 538bp for the 
knockout allele. 
Animals were housed at the Whitehead Institute 
for Biomedical Research and maintained 
according to protocols approved by the 
Massachusetts Institute of Technology Committee 
on Animal Care. 
 
Cell culture - MEFs were generated from E13.5 
fetuses and cultured in DME medium 
supplemented with 10% IFS, 1 mM glutamine and 
10 mM β-mercaptoethanol (MEF medium). In the 
experiments described here, matched pairs of 
primary wild type and knock-out MEFs from 
2
Male Ube2j1-/- mice are sterile 
 
 
littermates were used (except for experiments with 
SV40, for which we used MEFs that had been 
immortalized by serial passage). 
B cells were isolated from spleens of Ube2j1-/- or 
CD19-Cre Ube2j1fl/fl mice and Cre-matched 
Ube2j1WT/WT littermates, respectively. Splenocytes 
were enriched for B cells by depletion of non-B 
cells using  ‘Mouse CD43 Dynabeads’ (Life 
Technologies; Grand Island, NY) according to the 
manufacturer’s protocol. B cells were cultured in 
Roswell Park Memorial Institute (RPMI) medium 
with 10% fetal calf serum, 1 mM glutamine, 
10mM β-mercaptoethanol and MEM non-essential 
amino acids (Gibco, Life Technologies; Grand 
Island, NY) (B cell medium). B plasma cells were 
induced by adding 1 µM CpG-DNA 1826 (a TLR9 
agonist, phosphorothioate backbone, 5’- 
TCCATGACGTTCCTGACGTT-3’; IDT, 
Coralville, IA) to the B cell medium for 4 days.  
Immunoblotting - Mouse organs were 
homogenized in PBS containing protease 
inhibitors (complete protease inhibitor cocktail 
tablets; Roche Applied Science, Indianapolis, IN) 
with a rotor-stator homogenizer (TissueRuptor; 
Qiagen, Gaithersburg, MD). Homogenates were 
made in PBS containing 1% (v/v) NP-40. MEFs 
were lysed in PBS with 0.1%. Samples were 
immunoblotted using standard techniques. 
Antibodies for immunoblotting - Antibodies to OS-
9 (NB100-519, rabbit polyclonal, 1/1000; Novus 
Biologicals, Littleton, CO), p97 (10R-P104a, 
mouse monoclonal, 1/1000; Fitzgerald, Acton, 
MA), EDEM-1 (affinity-purified rabbit polyclonal, 
1/1000; Sigma-Aldrich, St. Louis, MO), Malectin 
(rabbit polyclonal, 1/1500; Abcam, Cambridge, 
MA) and HRD-1 (NB100-2526, rabbit polyclonal, 
1/1000; Novus Biologicals, Littleton, CO) were 
obtained commercially. Antibodies to XTP3-B 
((8), rabbit polyclonal serum, 1/5000; gift from 
Ron Kopito, Stanford) and ATF6 ((9), affinity-
purified rabbit polyclonal, 1/500; gift from Ronald 
Wek, University of Indiana) have been described 
before. Anti-UBE2J1 ((5), rabbit polyclonal 
serum, 1/4000), anti-gp96 (rabbit polyclonal 
serum, 1/4000), anti-SEL1L ((10), rabbit 
polyclonal serum, 1/4000), anti-PDI (rabbit 
polyclonal serum, 1/4000), UBXD8 ((5), rabbit 
polyclonal serum, 1/4000), Derlin-1 ((11), rabbit 
polyclonal serum, 1/4000), Derlin-2 ((11), rabbit 
polyclonal serum, 1/4000) and YOD1 ((12), 
affinity-purified rabbit polyclonal, 1/1000) were 
produced by our laboratory. 
Antibodies for FACS analysis - The antibodies 
used were anti-mouse IgM PE (clone II/41; 
eBioscience, San Diego, CA), anti-mouse B220 
Pacific Blue (clone RA3-6B2; BD Pharmingen, 
San Jose, CA), anti-mouse AA4.1 (CD93) PerCP-
Cy5.5 (clone AA4.1; eBioscience, San Diego, 
CA), anti-mouse CD1d PE (clone 1B1; 
eBioscience, San Diego, CA), anti-mouse 
CD21/CD35 APC (clone 7E9; BioLegend, Inc., 
San Diego, CA), anti-mouse CD23 FITC (clone 
B3B4; BD Pharmingen, San Jose, CA), anti-
mouse CD19 FITC (clone 1B3; BD Pharmingen, 
San Jose, CA), anti-mouse CD5 PerCP-Cy5.5 
(clone 53-7.3; eBioscience, San Diego, CA) and 
anti-mouse CD43 PE (clone S7; BD Pharmingen, 
San Jose, CA). 
Pulse-chase analysis - Plasmablasts were analyzed 
after four days of culture in B cell medium with 1 
µM CpG-DNA 1826. Cells were pretreated for 
five hours with 1 µg/ml tunicamycin (T7765; 
Sigma-Aldrich, St. Louis, MO) or left untreated, 
then starved for 1 hour in serum-free RPMI 
medium followed by a 20 minute labeling period 
with 35S-cysteine/methione (EXPRE35S35S 
Protein Labeling Mix, NEG072014MC; 
PerkinElmer, Inc, Waltham, MA). Aliquots were 
taken after chase periods of 0, 30, 60 and 120 
minutes. The supernatants were saved for 
immunoprecipitation. Cells were washed once in 
ice-cold PBS and lysed in NET buffer (50 mM 
Tris pH7.4, 150 mM NaCl, 0.5% v/v NP-40, 5 
mM EDTA) with complete protease inhibitors. 
Equivalent amounts of radiolabeled proteins were 
used for immunoprecipitations. IgM was 
immunoprecipitated with a µ chain-specific goat 
anti-mouse IgM antibody (1020-01; Southern 
Biotech, Birmingham, AL). Class I MHC was 
immunprecipitated with an H-2Kb heavy chain-
specific rabbit serum (p8, produced in our 
laboratory according to (13)). 
RNA isolation and RNA-Seq analysis - RNA for 
the RNA-Seq analysis was isolated from passage 
three MEFs with an RNeasy Plus Mini Kit 
according to the manufacturer’s protocol. Total 
RNA was analyzed for integrity with the RNA 
Pico kit on an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). Total RNA input 
amounts for library preparation were normalized 
and libraries were prepared using the Illumina 
3
Male Ube2j1-/- mice are sterile 
 
 
TruSeq TM V2 RNA Library Preparation Kit 
(Illumina, Inc., San Diego, CA) following the 
manufacturer’s protocol with slight modifications 
in the PCR step. Fifteen cycles of PCR were done 
using the HiFi NGS Library Amplification kit 
(KAPA Biosystems, Wilmington, MA). The 
libraries were quantified by qPCR using the 
Illumina Library Quantification kit (KAPA 
Biosystems, Wilmington, MA) according to the 
manufacturer’s protocol and sized using the High 
Sensitivity DNA kit from Agilent (Agilent 
Technologies, Santa Clara, CA). The RNA-Seq 
libraries were sequenced using the Illumina HiSeq 
2000 instrument (Illumina, Inc., San Diego, CA) 
for 40 bases (unidirectional). Sequence as well as 
quality scores were generated using the Off-Line 
Basecaller software (version 1.9.4; Illumina, Inc., 
San Diego, CA). FACS analysis - Single cell 
suspensions of bone marrow cells, splenocytes and 
peritoneal cavity cells were prepared and red 
blood cells were lysed. Cell suspensions were 
adjusted to the same concentration before surface 
staining in PBS with 2% fetal calf serum. To 
measure SV40 large T antigen expression, MEFs 
were fixed and permeabilized. SV40 Large T 
antigen was stained with a monoclonal mouse 
anti-SV40 large T antigen antibody ((14); gift 
from Ari Helenius, ETH Zurich) and goat anti-
mouse IgG AlexaFluor647 (A21235; Life 
Technologies). Samples were analyzed on a BD 
FACSCalibur or BD LSRII flow cytometer and 
data were processed using FlowJo software 
(TreeStar, Ashland, OR). 
ER stress induction and analysis - ER stress was 
induced in MEFs by culturing cells in MEF 
medium with tunicamycin (T7765; Sigma-
Aldrich) at the indicated concentrations. Induction 
of ER stress was assessed by immunoblotting for 
ATF6 or RT-PCR for splicing of the XBP-1u 
mRNA. For the the XBP-1u RT-PCR, RNA from 
stimulated cells was isolated with an RNeasy mini 
kit (Qiagen, Gaithersburg, MD) and cDNA was 
generated by reverse transcription using oligo-dT 
primers (SuperScript® III First-Strand Synthesis 
System; Life Technologies). cDNAs of the XBP-
1u (unspliced) and XBP-1s (spliced) mRNAs were 
detected by PCR amplification of a sequence 
surrounding the excised intron (forward: 5’-
GAACCAGGAGTTAAGAACACG-3’; reverse: 
5’-AGGCAACAGTGTCAGAGTCC-3’). 
SV40 assays - SV40 was produced and titrated in 
simian CV-1 cells and crude virus extracts 
obtained as described (15). For infection 
experiments, cells were seeded at a confluency of 
~60%. On the day of the experiment cells were 
washed with PBS and infection medium (RPMI, 
3% BSA, 10 mM HEPES pH6.8), then covered 
with SV40 infection inoculum for 4 hours. 
Subsequently the inoculum was removed and 
replaced with MEF medium. Cells were detached 
with trypsin 16 hours later and fixed for FACS 
staining of the large T antigen (see above). 
In vitro Fertilization (IVF) - Cumulus oocytes 
complexes (COCs) were isolated from 4-5 weeks 
old mice, superovulated C57BL/6NTac (Taconic, 
Hudson, NY) mice. Sperm from Ube2j1-/- mice 
and wild type littermates were isolated from 
caudal epididymides. After 10 minutes at 37°C/5% 
CO2, sperm cells were video documented, counted 
and normalized before incubation with COCs. 
Embryos of different developmental stages were 
counted once a day for three days. The remaining 
sperm were spread on glass microscopy slides, 
fixed for 10 minutes in 100% ethanol and 
morphologically assessed under a phase contrast 
microscope.  
Analysis of male reproductive organs - Testes and 
epididymides were fixed in Bouin’s solution or 
4% paraformaldehyde overnight and then 
processed into paraffin wax. Periodic acid-Schiff 
(PAS) stain performed following the 
manufacturers instructions (Sigma 395B-1KT). 
For immunohistology, tissues were rehydrated and 
antigen retrieval was performed in citrate buffer 
(Spring Bioscience, Pleasanton, CA). After 
blocking in 10% normal donkey serum, primary 
antibodies were applied in PBS for 2 h at 37°C. 
Sections were then washed and 
immunolocalization was performed with DyLight-
conjugated secondary antibodies (Jackson 
ImmunoResearch Laboratories, West Grove, PA), 
stained with 50 µg/ml lectin PNA (Molecular 
Probes) for 5 min and mounted using ProLong 
Gold with Dapi (Life Technologies). Antibodies 
used were anti-VASA (AF2030, goat polyclonal, 
0.3 µg/ml); R&D biosystems, Minneapolis, MN) 
and anti-UBE2J1 ((5), rabbit polyclonal serum, 
1/200, produced in our laboratory). 
Electron microscopy - Testes and epididymides 
were fixed in 2.5% gluteraldehyde, 3% 
paraformaldehyde with 5% sucrose in 0.1M 
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sodium cacodylate buffer (pH 7.4), and post fixed 
in 1% osmium tetroxide in veronal-acetate buffer. 
Epidydimal sperm cells were embedded in agar 
prior to further processing. Samples were stained 
in block overnight with 0.5% uranyl acetate in 
veronal-acetate buffer (pH6.0), then dehydrated 
and embedded in Embed-812 resin. 50 nm sections 
were cut on a Leica Ultracut UCT microtome with 
a Diatome diamond knife, and stained with uranyl 
acetate and lead citrate. The sections were 
examined using a FEI Tecnai Spirit at 80KeV. 
 
RESULTS 
Conditional ablation of Ube2j1 
We inserted LoxP sites into intron 1 and 3 of the 
Ube2j1 gene to allow conditional ablation of 
Ube2j1 (Fig. 1A). Correctly targeted ES cell 
clones were injected into blastocysts and the 
resulting male chimeras were crossed to FLPe 
transgenic females to delete the Neo cassette in 
Exon 3, which is flanked by Frt sites. Whole body 
knockout mice were obtained by crossing ‘floxed’ 
mice to CMV-Cre transgenic animals. Intercrosses 
of Ube2j1+/- animals yielded progeny of all 
possible genotypes as assessed by PCR. MEFs 
were generated from fetuses on gestation day 
E13.5. RNA-Seq analysis confirmed the deletion 
of specifically exons 2 and 3 (Fig. 1B). Analysis 
of lysates from Ube2j1-/- MEFs showed the 
complete absence of the UBE2J1 protein as 
assessed by immunoblot. Levels of UBE2J1 in 
Ube2j1+/- MEFs were reduced by half, indicative 
of a gene dosage effect (Fig. 1C). The additional 
bands in the wild type and heterozygous samples 
with apparent molecular weight of ~30 kDa 
(asterisk in Fig. 1C) might represent a so-far 
uncharacterized splice variant of Ube2j1. Indeed, 
exon junction analysis of the RNA-Seq data 
supported skipping of Exon 7 (data not shown). 
Ube2j1-/- mice fail to thrive early after birth 
Litters from heterozygous parents were born at the 
expected Mendelian ratios (Fig. 1D), and the 
weight of P0.5 pups was similar for wild type, 
heterozygous and knockout animals (Fig. 1E, top 
panel). At weaning (P21), approximately half of 
the knockout animals had died (Fig. 1D), the 
survivors were smaller in size and weighed 
significantly less than wild-type animals (Fig. 1E, 
bottom panel). Ube2j1+/- mice had intermediate 
body weights at P21 (Fig. 1E, bottom panel), 
concordant with intermediate expression levels of 
UBE2J1 seen in heterozygous MEFs (Fig. 1C). 
We identified milk spots one day after birth in 
both wild type and Ube2j1-/- mice, excluding the 
inability to feed as possible reason for the failure 
to thrive. We did not observe enhanced mortality 
in Ube2j1-/- animals after weaning. Thus, while the 
lack of Ube2j1 does not impair development or 
growth of embryos in the gestation phase, Ube2j1 
is important for postnatal survival and growth. 
Specific components of the ER dislocation 
machinery are upregulated in the absence of 
UBE2J1 
Removal of key components of a quality control 
pathway is expected to result in accumulation of 
misfolded proteins and might therefore activate the 
unfolded protein response (UPR). However, we 
did not observe constitutive activation of the UPR 
in Ube2j1-/- MEFs as judged by the splicing status 
of the Xbp-1 mRNA (Fig. 3A and 3B), cleavage 
status of ATF6 (Fig. 3C), and protein (Fig. 2A and 
B) or transcript levels (Fig. 2D and data not 
shown) of genes known to be upregulated upon 
ER stress, unlike what was described in Derlin-2-/- 
MEFs (16). However, when we examined protein 
levels of ER proteins in MEFs (Fig. 2A) and in 
lysates prepared from different tissues (Fig 2B and 
C), we found that OS9, SEL1L and EDEM1 levels 
were increased in Ube2j1-/- MEFs. The observed 
increase varied with tissue and/or cell-type 
examined. For example, OS9 was barely 
detectable in skin from wild type mice, but present 
at a much higher level in skin from a knockout 
mouse. While the increase was modest in the large 
intestine (~2-fold), changes in OS9 levels in MEFs 
(Fig. 2B), pancreas, thymus and spleen were 
considerably higher (~5-10-fold, Fig. 2B). 
Quantitative analysis of RNA-Seq data from 
MEFs did not show changes similar to those 
observed in the immunoblots (Fig. 2D and data not 
shown), implying that increased transcription of 
the corresponding genes is not the reason for this 
observation. Regulation at the translational level 
also seems unlikely, because levels of other 
proteins, including components of the dislocation 
machinery such as HRD1, XTP3B, Derlin-1 or 
Derlin-2, were unaffected (Fig. 2A). The RNA-
Seq data confirmed the absence specifically of 
exons 2 and 3 of Ube2j1 in Ube2j1-/- MEFs (Fig. 
1B). Therefore we can conclude with confidence 
that similar RKPM values for other genes of 
interest, including those encoding ER quality 
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control components, reflect similar levels of 
transcripts. 
Taken together, ablation of Ube2j1 results in the 
accumulation of specific proteins of the ER quality 
machinery, probably by their post-translational 
stabilization.  
Ube2j1-/- MEFs are more susceptible to SV40 
infection 
Having shown upregulation of EDEM1, OS9 and 
SEL1L in Ube2j1-/- MEFs, we asked whether there 
are functional consequences to this remodeling of 
the ER. ER dislocation components are required 
for transport of SV40 from the ER to the cytosol 
(15,17). An increase in the concentration of 
components involved in ER quality control might 
therefore facilitate escape of SV40 from the ER. 
We infected knockout and wild type MEFs with 
SV40 and quantified infection 20 h later by flow 
cytometry using antibodies for SV40 large T 
antigen (TAg). Ube2j1-/- MEFs were indeed more 
susceptible to SV40 infection than WT MEFs (Fig 
2E).  To test whether enhanced susceptibility of 
Ube2j1-/- MEFs to infection was not simply due to 
an increase in the SV40 receptor, the ganglioside 
GM1, we measured binding of FITC-labeled 
Cholera Toxin B subunit (FITC-CTxB), which 
also uses GM1 to bind to cells (18). FITC-CTxB 
bound equally well to wild-type and knockout 
MEFs (Fig. 2F). Wild type and Ube2j1-/- MEFs 
were equally susceptible to infection with 
vesicular stomatitis virus (VSV), a virus that does 
not require ER quality control components for 
infection (data not shown). SV40 thus infects 
Ube2j1-/- MEFs more successfully than wild type 
MEFs, in agreement with the increased levels of 
ER quality control components implicated in virus 
escape from the ER. These components must 
therefore be properly integrated in the pathway 
exploited by SV40. 
Ube2j1-deficiency does not enhance induction of 
the unfolded protein response (UPR) 
UBE2J1 is one of three E2 ubiquitin conjugating 
enzymes involved in ER dislocation, and was 
identified as part of the HRD1-SEL1L complex. 
We reasoned that its absence might impair the 
ability of cells to cope with ER stress and thus 
render cells more susceptible to the UPR. We 
therefore exposed MEFs to tunicamycin, an 
inhibitor of N-linked glycosylation that potently 
induces the UPR. We neither observed differences 
in the extent of Xbp-1 splicing (Fig. 3B), nor in the 
processing of ATF6 (Fig. 3C) in response to 
tunicamycin treatment. We also did not see 
differences in response to other inducers of the 
UPR, such as depletion of ER-resident calcium 
stores by thapsigargin or by perturbation of redox 
homeostasis by DTT (data not shown). 
Notably, steady-state levels of full-length ATF6 
were higher in Ube2j1-/- MEFs (Fig. 3C). ATF6 is 
itself a substrate that is degraded in a SEL1L-
dependent manner (19). Given that mRNA levels 
of Atf6 are unaltered in Ube2j1-/- MEFs (Fig. 2D), 
it is likely that turnover of ATF6 involves the 
action of UBE2J1, a component of the SEL1L-
containing dislocon, possibly by directly 
transferring ubiquitin onto dislocated ATF6.  
We conclude that Ube2j1-deficiency does not 
render MEFs more susceptible to ER stress. 
B cell development, immunoglobulin maturation 
and immunoglobulin secretion are normal in 
Ube2j1-/- B cells 
The prevailing view is that ER quality control is 
especially important for tissues and cells with a 
high secretory load, such as liver, pancreas and B 
lymphocytes. However, surviving Ube2j1 
knockout mice were seemingly healthy once they 
reached adulthood. Considering the compensatory 
mechanism(s) observed in MEFs, we reasoned that 
a phenotype might be observable only under non-
homeostatic conditions or in cells with a high 
secretory load. We therefore asked if B cell 
function is affected in the absence of Ube2j1.  
Ube2j1-/- mice had similar frequencies of 
immature (B220intIgM+), pre-/pro- (B220+IgM-) 
and recirculating (B220hiIgM+) B cells in the bone 
marrow as wild type mice (Fig. 4A). We also 
observed no difference in frequencies of immature 
(B220+AA4.1+), mature (B220+AA4.1-), follicular 
(B220+AA4.1+CD21loCD1dlo), marginal zone B 
cell precursors 
(B220+AA4.1+CD21hiCD1dhiCD23+) and marginal 
zone B cells (B220+AA4.1+CD21hiCD1dhiCD23-) 
in the spleen (Fig. 4A). The average frequencies of 
total B1 (B220loCD19+), B1a 
(B220loCD19+CD5+), B1b (B220loCD19+CD5-) 
and B2 (B220hiCD19+) cells in the peritoneal 
cavity were comparable between Ube2j1-/- and 
Ube2j1+/+ control animals (Fig. 4A). We conclude 
that B cell development is normal in the absence 
of UBE2J1.  
B cells have been used extensively to study the 
impact of chaperone-dependent protein folding as 
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well as other aspects of glycoprotein quality 
control, precisely because of their exceptionally 
high rates of synthesis, assembly and secretion of 
immunoglobulins ((20) and references therein). 
Therefore, we analyzed bulk glycoprotein 
synthesis and turnover in B cell plasmablasts. 
Spleens from CD19-Cre Ube2j1fl/fl and CD19-Cre 
Ube2j1wt/wt were enriched for B cells by exclusion 
of CD43+ cells. CD43- cells were then stimulated 
with 1µM CpG-DNA for four days to obtain B 
plasmablasts. Plasmablasts were metabolically 
labeled with 35S-cysteine/methionine and the fate 
of both intracellular and secreted immunglobulins 
was followed. Maturation and secretion of 
immunoglobulin or maturation of the class I MHC 
molecule H2-Kb were indistinguishable between 
Ube2j1-/- and control mice (Fig. 4B). Imposition of 
additional ER stress by exposure of plasmablasts 
to tunicamycin for 5 hours prior to pulse-chase 
analysis did not show any differences in stability 
or secretion of immunoglobulins either (Fig. 4C). 
In the aggregate, UBE2J1 is required neither for B 
cell maturation nor is it essential for synthesis, 
assembly or secretion of immunoglobulins by B 
plasmablasts. The lack of detectable alterations in 
the overall composition of serum proteins, 
produced mostly by the liver, is also consistent 
with this conclusion (data not shown). 
Male Ube2j1-/- mice are sterile 
In our attempt to breed Ube2j1-/- animals we 
readily obtained litters from Ube2j1-/- females 
intercrossed with heterozygous males. In contrast, 
breeding pairs with male Ube2j1-/- animals (n=6) 
produced no offspring. When co-housing 
individual male Ube2j1-/- animals overnight with 
heterozygous females, vaginal plugs were 
observed, indicating that Ube2j1-/- males were 
sexually active, but no pregnancies were observed. 
To understand the underlying defect of this 
observation we first analyzed epididymal sperm. 
The total numbers of sperm cells isolated from 
epididymides of Ube2j1-/- mice were significantly 
reduced (Fig. 5A). Since the amount of residual 
sperm might still be sufficient to confer fertility 
(21,22), we asked if the remaining sperm cells are 
functional. We found that the motility of 
spermatozoa isolated from the epididymis was 
severely impaired in Ube2j1-/- mice (Fig. 5B, 
Movie S1) as compared with wild type controls 
(Fig. 5B, Movie S2), pointing to defects in flagella 
function. Ube2j1-/- animals had a strikingly 
increased frequency of sperm cells with aberrant 
morphologies (91% vs. 26% normal, 4% vs. 59% 
with abnormal head morphology, 5% vs. 15% 
acephalic sperm in wild type vs. Ube2j1-/- sperm, 
respectively; Fig. 5C and D). Further, epididymal 
sperm preparations from Ube2j1-/- mice contained 
cell debris (Movie S2). Next, we tested if sperm 
from Ube2j1-/- mice could fertilize eggs in vitro. 
We incubated sperm from wild type (Movie S3) or 
Ube2j1-/- (Movie S4) mice with eggs from wild 
type mice. Sperm cells from Ube2j1-/- mice rarely 
bound to isolated eggs, consistent with abnormal 
sperm function and were unable to fertilize eggs. 
One day after IVF, we observed a single 2-cell 
embryo with sperm from Ube2j1-/- animals (n=3 
males, ~200 eggs per male), which did not survive 
to the 4-cell stage. In contrast, ~54% of the eggs 
fertilized with sperm from wild type males 
proceeded to the 2-cell stage one day after IVF 
(n=3 males, ~200 eggs per male). By day 3.5 after 
IVF, ~36% of the eggs fertilized with control 
sperm reached the morula stage and ~17% had 
developed into a blastocyst. In contrast, all eggs 
that had been incubated with Ube2j1-/- sperm had 
died or had not proceeded to the 2-cell stage (Fig. 
5E). Given its severely reduced mobility (Movie 
S2) and impaired ability to bind to the zona 
pellucida (Movie S4), Ube2j1-/- sperm most 
probably did not efficiently fertilize the oocytes, 
although we cannot formally exclude a defect in 
the sperm’s ability to support post-fertilization 
embryo development. 
Taken together, male Ube2j1-/- mice are sterile. 
Their sperm cells are morphologically abnormal, 
display severely impaired mobility and cannot 
generate multi-cell embryos in an IVF setting. 
Male Ube2j1-/- mice have defects in spermatid 
development 
Considering that Ube2j1-/- spermatozoa are 
defective and given that UBE2J1 is highly 
expressed in testicular extracts (Fig. 2C), we next 
investigated the role of Ube2j1 in 
spermatogenesis. Immunolocalization of UBE2J1 
revealed strong expression in the early maturation 
phase of elongate spermatids between step 12 and 
15 (Fig. 6A), a period in which the ER undergoes 
massive, dynamic changes, as previously 
described (23). This expression gradually 
diminished as spermatids reduced their 
cytoplasmic content, consistent with the regression 
of the ER at this time (23,24). The specificity of 
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the staining with the anti-UBE2J1 antibody is 
validated by the absence of staining in Ube2j1-/- 
testis sections (Fig. 6A, right panel). We did not 
detect UBE2J1 in meiotic or mitotic germ cells 
(Fig. 6B).  
The expression of UBE2J1 in elongate spermatids 
in conjunction with reduced epididymal sperm 
number, motility and morphology in Ube2j1-/- 
mice suggested a defect in the final phases of germ 
cell maturation. To assess spermatogenesis, we 
performed periodic acid-Schiff (PAS) stains on 
testis sections. Mouse spermatogenesis is 
characterized by a defined set of germ cell 
associations, by which germ cell stem cells 
(spermatogonia) differentiate and progress through 
meiosis and spermiogenesis to produce haploid 
spermatozoa for fertility. At stage VIII of 
spermatogenesis, elongate spermatids are released 
into the tubular lumen in a process known as 
spermiation (25). Haploid round spermatids, 
previously located immediately basal to elongate 
spermatids, then start a dramatic morphological 
transformation into elongate spermatids from late 
stage VIII onwards. In this way, only one 
generation of elongate spermatids is observed at 
any stage of mouse spermatogenesis (26). In 
Ube2j1-/- mice, we frequently observed abnormal 
germ cell associations, with retained elongate 
spermatids from stage IX onwards (Fig. 6C), 
indicative of defective spermiation (25). These 
spermatids are subsequently released into the 
tubular lumen, or phagocytosed by the 
seminiferous epithelium (asterisks in Fig.6C).  
We also observed focal regions of mixed 
hypospermatogenesis in all Ube2j1-/- mice 
examined (data not shown), indicating that 
additional spermatogenic defects may contribute 
to compromised fertility in these males.  
The average weights of testes from wild type, 
heterozygous and Ube2j1-/- males were all similar, 
although we observed substantially smaller testes 
in a few knockout animals (Fig. 6D). 
We conclude that spermatid development is 
defective in Ube2j1-/- mice as manifested by 
frequent abnormal germ cell associations. 
Structural abnormalities in Ube2j1-/- sperm 
To gain further insight into the defects imposed on 
spermatids by the lack of Ube2j1, we analyzed the 
ultrastructure of the testis and epididymal sperm 
by electron microscopy. Fig. 7A shows stage IX 
spermatids and retained spermatids (asterisks) in a 
stage IX seminiferous tubule form the testis of a 
Ube2j1-/- mouse. Both spermatids retained in the 
testis (Fig. 7A) and epididymal sperm cells from 
Ube2j1-/- mice (Fig. 7C, D, F and G) showed the 
presence of cytoplasm around their acrosome and 
neck, an abnormality not observed in sperm from 
wild type testes (Fig. 7B) or epididymides (Fid. 7E 
and H). This excess cytoplasm contained 
organelles, such as endoplasmic reticulum and 
vacuoles surrounded by one or more membranes. 
The massively condensed ER morphology (Fig. 
7D and G) is reminiscent of the ‘radial body’ 
described in (23), which is the typical form of 
appearance of the ER at steps 14-15 of spermatid 
development. The ‘radial body’ denotes a 
condensed, aggregated, glomerulus-like 
appearance of the ER at the posterior side of the 
cell (23). We also observed excess residual 
cytoplasm in the midpiece of Ube2j1-/- epididymal 
sperm (data not shown), a pathological form of 
cytoplasmic droplets (27). Cytoplasmic droplet in 
mice are a cellular structure of epididymal sperm 
implicated in sperm motility and an indicator for 
normal spermiogenesis (28). Excess residual 
cytoplasm around the midpiece in Ube2j1-/- sperm 
might confer the instability responsible for the 
elevated number of acephalic sperm in the sperm 
smear (Fig. 5C), and defects in flagella function 
(Movie S2). Acrosome formation and the (9+2) 
organization of microtubules in the sperm tails 
seem to be intact. However, the subacrosomal and 
perinuclear space were often expanded, leading to 
the detachment of the acrosome from the 
condensed nucleus (Fig. 7C and F). Together, the 
EM data suggest that cytoplasm removal cannot be 
completed in absence of Ube2j1. This failure of 
cytoplasmic remodeling initiates a cascade of 
events that ultimately leads to infertility. 
 
DISCUSSION 
The removal and degradation of misfolded or 
unwanted ER proteins is a process pivotal to 
maintain homeostasis in the ER. Here, we 
characterized mice deficient in the ER-anchored 
E2 ubiquitin-conjugating enzyme UBE2J1, which 
is part of an E2/E3 ubiquitin ligase complex that 
marks substrates destined for extraction from the 
ER and degradation by the proteasome. 
Gestation proceeds normally in Ube2j1-/- mice and 
adult animals look normal and show no aberrant 
behaviors. Nonetheless, approximately half of 
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Ube2j1-/- mice die early in life, and surviving adult 
Ube2j1-/- mice have significantly reduced body 
weight, suggesting that there is a critical period 
after birth for which a proper level of UBE2J1 is 
required. 
In the absence of Ube2j1, specific proteins 
involved in ER quality control, such as OS9, 
EDEM1 and Sel1L, are upregulated resulting in 
higher susceptibility to infection by SV40. Why 
the levels of some but not other components 
implicated in ER quality control show an increase 
is unclear. The amount of such components, 
perhaps not surprisingly, may be controlled 
dynamically (29,30), according to the immediate 
needs of the cell. In vivo ablation of Ube2j1-/- may 
thus reveal the existence of a feedback loop in 
which activation of Ube2j1 attenuates the levels of 
OS9, EDEM1 and Sel1L. At present we do not 
know whether ablation of UBE2J1 directly 
stabilizes OS9, SEL1L or EDEM1 and proteins in 
the same functional category, or if, owing to the 
Ube2j1 deficiency, unfolded proteins accumulate 
first and then trigger upregulation or stabilization 
of the latter proteins. Regardless of the exact 
sequence of events, the observed compensation 
does not seem to involve the UPR. These findings 
point to a remarkable robustness and redundancy 
within the ER quality control system to restore 
and/or maintain ER homeostasis. 
Notwithstanding the absence of a constitutive 
activation of the UPR, it is intriguing that ATF6 is 
stabilized in Ube2j1-/- cells. As part of the 
HRD1/SEL1L complex, UBE2J1 might required 
for turnover of ATF6, consistent with the recent 
finding that ATF6 is stabilized in absence of 
SEL1L (19). 
The most striking phenotype observed in Ube2j1-/- 
mice is a profound defect in spermatid 
differentiation, known as spermiogenesis, resulting 
in male sterility. The massive morphological 
changes in the course of spermiogenesis include 
synthesis of the acrosome, chromatin condensation 
and elongation of the nucleus, formation of the 
flagellum and remodeling of membrane-delimited 
organelles. In the final step, called spermiation, 
remaining cytoplasm is eliminated from the 
spermatid, intercellular cytoplasmic bridges 
between spermatids are disrupted, and the strong 
adhesions between spermatids and the Sertoli cell 
(ectoplasmic specializations), with which they 
intimately interact, are removed to facilitate their 
release into the lumen of the seminiferous tubule 
(25). UBE2J1 protein was abundantly present in 
elongating spermatids, specifically from step 12 to 
15 of sperm differentiation (31), peaking at step 
14. Spermatids at these differentiation steps are 
largely transcriptionally inactive (32,33), implying 
that the transcripts are transcribed earlier, and that 
translation of the Ube2j1 (and presumably other) 
transcripts is de-repressed in elongate spermatids 
(34). Thus, UBE2J1 is likely required at a critical 
time within the elongating spermatid itself for 
successful completion of the final steps of 
differentiation and spermiation. Crossing 
Ube2j1fl/fl mice with a germ-cell specific (e.g. 
Stra8-Cre) or a Sertoli cell-specific Cre-deleter 
strain (e.g. Amh-Cre) may allow us in the future to 
unequivocally determine the cell-type(s) that is/are 
responsible for the defect in spermiogenesis. 
Pups from Ube2j1+/- parents are born at expected 
Mendelian ratios, suggesting that in heterozygous 
mice, Ube2j1- (haploid) sperm are fully functional. 
This might be explained by the distribution of 
cellular contents between cells of a clone derived 
from one Ube2j1+/- spermatogonium via 
cytoplasmic bridges (35). Ube2j1 transcripts 
would thereby be shared between adjacent cells of 
the syncytium, allowing proper differentiation of 
both Ube2j1+ and Ube2j1- spermatids. 
Why is spermiation not executed correctly in 
Ube2j1-/- testes? Microscopic examination showed 
aberrant spermatozoa and cellular debris in 
epididymal sperm preparations. Ultrastructural 
examination of epididymal sperm by electron 
microscopy revealed excess residual cytoplasm in 
the head and midpiece region of spermatozoa. 
These observations are in line with the notion that 
Ube2j1 is critical for cytoplasmic removal during 
the last steps of spermatid differentiation. 
Considerable structural changes during 
spermiogenesis in different organelles, particularly 
the ER, have been observed  by TEM and SEM 
(23). The structural metamorphosis of the ER 
starts from a branched network of tubular 
structures, which are spread evenly throughout the 
cytoplasm (step 13), over a markedly condensed, 
glomerular structure (radial body, step 14), to a 
completely degenerated structure, often 
aggregated with other organelles (step 15). At step 
16, immediately prior to sperm release, the ER is 
no longer detectable (23). Levels of UBE2J1 are 
highest precisely when the ER is massively 
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remodeled for eventual elimination (steps 13 to 
16). We hypothesize that Ube2j1 is involved in the 
aforementioned remodeling process, possibly by 
marking excess proteins for proteasomal 
degradation. In the absence of Ube2j1, ER luminal 
proteins that depend on active UBE2J1 for their 
removal might be trapped in the ER and block 
further condensation of the ER. This might prevent 
the cell from completing the necessary removal of 
cytoplasm, as evidenced by excess residual 
cytoplasm in the head reagion, accompanied by 
detached acrosomes, and around the midpiece, 
probably causing defects in flagella function. 
Abnormal spermatids are likely sensed by Sertoli 
cells eventually resulting in the spermatid 
retention and ultimately, phagocytosis by Sertoli 
cells. This failure of spermiation likely explains 
the starkly reduced sperm number in the 
epididymis.  
Although essential for the generation of functional 
sperm cells, how cytoplasmic removal is 
accomplished in elongating spermatids and which 
genes are involved in this process is not well 
understood. In fact, most genes so far associated 
with defective cytoplasmic removal encode 
nuclear proteins, such as transition nuclear 
proteins (Tnp1, Tnp2, (36)) and the protamines 
(Prm1, Prm2, (37)), none of which are likely to 
directly participate in cytoplasm removal. 
An exception might be LKB1 (Liver kinase B1), a 
kinase that is predominantly found in the 
cytoplasm and membrane fractions. Their 
phenotype with respect to male infertility is 
strikingly similar to Ube2j1-/- mice. However, 
unlike in Ube2j1-/- mice, the epididymis is 
completely filled with cell debris in LKB1-/- mice, 
and LKB1 is expressed in both meiotic and post-
meiotic cells. 
An intriguing case is SPEM1 (spermatid 
maturation 1), a protein of unknown molecular 
function, which is expressed exclusively in 
elongating spermatids between steps 14 and 16, 
implying a function in cytoplasm removal and/or 
spermiation (38). Akin to Ube2j1-/- mice, SPEM1-/- 
males (but not females) are sterile and their sperm 
are ~85% immotile because of severe 
deformations in the head/neck region, caused by 
retention of cytoplasmic remnants. The 
ultrastructural characteristics are strikingly similar 
to our observations in Ube2j1-/- sperm (38). 
SPEM1 interacts with UBQLN1 (ubiquilin 1) at 
the manchette of elongating spermatids (39). 
Although it was postulated that UBQLN1 
participates in spermiogenesis, in vivo support for 
this is still pending. UBQLN1 and its homologue 
UBQLN2 form a complex with p97/VCP and 
erasin, both of which are central components of 
the ER dislocation machinery (40). UBE2J1, 
UBQLN1 and SPEM1 may function co-
operatively during the removal of cytoplasm from 
elongating spermatids. 
Taken together, we identify Ube2j1 as a key 
player in the elongation of spermatids, arguably 
one of the most extreme examples of structural 
and morphological reorganization of a cell. The 
role of Ube2j1 in this context is unique and non-
redundant, since Ube2j1’s paralogue Ube2j2 
cannot compensate for the defect in 
spermiogenesis. Ube2j1 is, to our knowledge, the 
first reported gene directly linking the little 
understood process of cytoplasm removal in 
elongating spermatids with the ubiquitin-
proteasome pathway, adding a new layer of 
regulation to spermiogenesis. Furthermore, our 
data define a previously unknown physiological 
function for ER dislocation, a cellular process, 
which until recently has been characterized mostly 
in established cell lines using biochemical assays. 
Examination of ER components in mouse models 
of male fertility might well prove informative to 
further elucidate the cellular processes that 
regulate spermiogenesis. 
Remarkably, components of the ubiquitin-
proteasome pathway, including Ube2j1, were 
amongst the most strongly and significantly 
differentially regulated genes in human in 
teratozoospermic sperm (41), suggesting that 
Ube2j1’s role in spermiogenesis may be conserved 
in humans. Considering that the genetic causes 
underlying spermiogenic failure in men are still 
largely unknown, Ube2j1 and other components of 
this pathway warrant closer examination and 
might be useful as diagnostic markers for male 
infertility in humans. 
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FIGURE LEGENDS 
 
FIGURE 1. Generation of Ube2j1fl/fl mice. Ube2j1-/- mice fail to thrive after birth. 
(A) Scheme of the targeting strategy. LoxP sites were introduced into introns 1 and 3 to allow excision of 
exons 2 and 3 by Cre recombinase. Circled A, B and C indicate annealing sites for the genotyping 
primers. (B) Representation of the reads measured for Ube2j1 by RNA-Seq in representative Ube2j1+/+ 
(WT) or Ube2j1-/- (KO) MEF lines (passage 3). The bottom panel depicts the intron/exon structure of 
Ube2j1. (C) Immunoblot of MEF lysates from two individual Ube2j1+/+, Ube2j1+/- or Ube2j1-/- embryos, 
each. Asterisk, potential splice variant. (D) Frequencies of sex and genotypes of pups from Ube2j1+/- 
parents at P0.5 (after birth) and P21 (weaning). (E) Weight of Ube2j1+/+, Ube2j1+/- and Ube2j1-/- mice at 
age P0.5 (top) and P21 (bottom). *: P<0.05; **: P<0.01; ***: P<0.001; n.s.: P>0.05, as determined by 
one-way ANOVA with Tukey’s Multiple Comparison Test. 
 
FIGURE 2. Ube2j1-/- MEFs and organs express higher levels of specific ER dislocation components, and 
Ube2j1-/- MEFs are more susceptible to SV40 infection. 
(A) Immunoblots of several components of the ER quality machinery in two independent Ube2j1+/+ (WT) 
or Ube2j1-/- (KO) MEF lines, respectively, show increased levels for specific ER quality control 
components in Ube2j1-/- MEFs. (B and C) Protein levels in organ lysates from a Ube2j1-/- mouse and a 
wild type littermate. SI: small intestine, LI: large intestine, SG: salivary gland, SM: skeletal muscle, LN: 
lymph nodes, Epi: epididymis. (D) Transcript levels of select genes involved in the ER stress response 
and ER dislocation are unaltered in Ube2j1-/-  MEFs. Shown are average reads per kilobase per million 
mapped reads (RPKM) values as determined by RNA-Seq from two independent MEF cell lines (passage 
3) per genotype. (E) Wild type or Ube2j1-/- MEFs were infected with different MOIs of SV40. 24 hours 
after infection the expression of the large T antigen was measured by FACS. Shown are mean and 
standard deviation values of relative percentages of infected cells of three independent experiment. **: 
P<0.01; ***: P<0.001, as determined by Student’s t tests. (F) Binding of Cholera Toxin B subunit (FITC-
CTxB) to wild type or Ube2j1-/- MEFs. Shown are mean MFI values and standard deviation of two wild 
type or two Ube2j1-/- MEF lines, respectively, from one representative experiment. 
 
FIGURE 3. Ube2j1-deficiency does not enhance induction of the UPR. 
(A) Representation of the reads measured for Xbp-1 by RNA-Seq. Shown are reads from unstimulated 
Ube2j1+/+ (WT) or Ube2j1-/- (KO) MEF lines (passage 3). The bottom panel depicts the intron/exon 
structure of Xbp-1. (B) Splicing of the Xbp1-mRNA after exposure of Ube2j1+/+ and Ube2j1-/- MEFs to 
tunicamycin as measured by RT-PCR. (B) Proteolytic processing of ATF6 after exposure of Ube2j1+/+ 
and Ube2j1-/- MEFs to tunicamycin measured by immunoblotting with an antibody directed to the N-
terminus of ATF6. 
 
FIGURE 4. B cell development and antibody secretion are normal in absence of Ube2j1. 
(A) FACS plots for markers of different B cell populations in the bone marrow, spleen and peritoneal 
cavity revealed no difference in B cell development in Ube2j1-/- mice. (B) and (C) Synthesis, maturation 
and secretion of immunoglobulin does not differ significantly between Ube2j1+/+ and Ube2j1-/- B cells. 
Shown are autoradiographs of immunoprecipitates for µ chain of IgM and class I MHC heavy chain from 
B plasmablast lysates (left column) and supernatants (right column) from a pulse-chase experiment (B) 
without or (C) with pre-treatment (5h) with tunicamycin. 
 
FIGURE 5. Ube2j1-deficiency causes male sterility in mice. 
 (A) Total number of sperm cells in the epididymis of Ube2j1+/+ (WT) or Ube2j1-/- (KO) mice. *: P<0.05, 
as determined by unpaired t test. (B) Progressive motility of Ube2j1-/- sperm cells is impaired. Shown are 
average percentages of (black) immotile, (white) non-progressively motile and (grey) progressively 
motile Ube2j1+/+ (WT) or Ube2j1-/- (KO) sperm cells (n≈200 per mouse, 3 mice per genotype). (C) 
Assessment of sperm cell morphology. Average percentages of (black) morphologically normal, (white) 
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acephalic and (grey) morphologically abnormal sperm cells as observed in an ethanol-fixed sperm smear 
are shown (n≈200 per mouse, 3 mice per genotype). (D) Photographs of ethanol-fixed Ube2j1+/+ (WT) or 
Ube2j1-/- (KO) spermatozoa. Note the abnormal head morphology in the knockout sperm. (E) Percentages 
of embryo stages observed in an IVF experiment one, two and 3.5 days after fertilization. Spermatozoa 
from Ube2j1+/+ (WT) or Ube2j1-/- (KO) mice (3 mice per genotype) were incubated with wild type 
oocytes (~200 oocytes per sperm of one male) and embryos at the indicated stages were counted.  
 
FIGURE 6. Male Ube2j1-/- mice have defects in spermatid differentiation. 
(A) Immunohistochemical staining for UBE2J1 (16), acrosomes (PNA lectin, red) and DNA (DAPI, blue) 
in testis cross-sections of a wild type mouse. Note the stage-specific expression of UBE2J1. No staining 
was detected in Ube2j1-/- testes (right panel). Scale bar: 10µm. (B) Immunohistochemical staining for 
UBE2J1 (16) and the germ cell-specific DDX4 (red) in a wild type testis. (C) PAS-stained cross-section 
of testes from Ube2j1+/+ (WT, top row) and Ube2j1-/- (bottom row) mice. Note the abnormal germ cell 
associations and spermiation defect at stage IX. Asterisks denote mislocated spermatids. Filled 
arrowheads: elongated spermatids to be released at the end of stage VIII. Empty arrowheads: next 
generation round spermatids. (D) Average testis weight in grams Ube2j1+/+ (WT), Ube2j1+/- (HET), and 
Ube2j1-/- (KO) mice. Shown are mean testis weight of individual mice (data points), and overall average 
with standard deviation. n.s.: P>0.05, as determined by one-way ANOVA with Tukey’s Multiple 
Comparison Test. 
  
FIGURE 7. Electron microscopy reveals structural abnormalities in Ube2j1-/- spermatozoa. 
(A) Cross sections of a Ube2j1-/- stage IX testis shows retained spermatids (asterisks) with cytoplasm 
(arrows) above a layer of elongate spermatids. ES: ectoplasmic specialization. (B) Wild type elongated 
spermatids in the testis. (C, D) Ube2j1-/- and (E) wild type spermatids in cross sectioned epididymides. (F, 
G) Ube2j1-/- and (H) wild type spermatids isolated from epididymides. Ube2j1-/- spermatozoa retain 
excess cytoplasm around the acrosome and neck region. Note vacuoles (wedges) surrounded by one or 
more membranes (F), and retained condensed ER (‘radial body’, insets) in Ube2j1-/- spermatozoa (C, D, 
F, G). Scale bars: (A, B): 2 µm; (C, D, E, F): 500 nm; (G): 100 nm; (H): 500 nm. 
 
15
A D
Targeting Vector
Targeting Construct
Targeted allele
+FLP recombinase
          +Cre recombinase
Disrupted allele Ube2j1 
Endogenuous allele
Ube2j1
1 2 3 4 5 6 7 8
Neo DTA
2 3 4
1 2 3 4 5
1 2 3 4 5
1 4 5
LoxP site
FRT site
Neo
Neo
DTA
5’ HA (~4.6kb) 3’ HA (~2.8kb)
A B C
A C
B
37kDa
50kDa
25kDa
UBE2J1
+/+ -/- +/-+/+ -/- +/-
P-UBE2J1
E
0.0
0.5
1.0
1.5
W
ei
gh
t i
n 
gr
am
s
0
5
10
15
W
ei
gh
t i
n 
gr
am
s
*
* *
* * *
n.s.n.s.
n.s.
MEFs
IB: anti-UBE2J1
Figure 1
+/- -/-+/+
+/- /-+/+ Ube2j1
Ube2j1
P0.5
P21
C
Ube2j1
KO
WT
*
16
A B
WT
Malectin
UBXD8
PDI
SEL1L
UBE2J1
XTP3B
Derlin-2
Derlin-1
C
OS9-1
PDI
long exp.
SEL1L
UBE2J1
PDI
KO
WTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKOWTKO
B
ra
in
LNS
pl
ee
n
Th
ym
us
S
M
H
ea
rt
Lu
ng
S
G
P
an
cr
ea
s
Li
ve
r
K
id
ne
y
LIS
I
O
va
ry
S
ki
n
p97
gp96
EDEM1
WT KO WT KO WT KO WT KO
Testis Epi LI SI
UBE2J1
Figure 2
OS9-2
OS9-1
OS9-2
MEFs
PDI
E F
WT
KO
0.0
01
10
0010
01010.10.0
1
FITC-CTxB (μg/ml)
M
ed
ia
n 
Fl
uo
re
sc
en
ce
 In
te
ns
ity
0
500
1000
2000
1500
SV40 titer
high medium low
0
600
400
200
R
el
at
iv
e 
%
 o
f i
nf
ec
te
d 
ce
lls
WT
KO
 
**
***
***
Os9
W
T KO
0
1000
2000
3000
4000 Sel1L
W
T KO
0
2000
4000
6000
8000
Edem1
W
T KO
0
1000
2000
3000
4000
5000
Ube2j1
W
T KO
0
1000
2000
3000
4000 Gapdh
W
T KO
0
200
400
600
Atf6
W
T KO
0
500
1000
1500
2000
2500
D
R
P
K
M
R
P
K
M
R
P
K
M
HRD1
YOD1
17
BC
IB: anti-ATF6
WT MEFs
0 1 5 0 1 5
150kDa
50kDa
100kDa
75kDa
full-length +CHO
full-length -CHO
N-terminal
Tunicamycin [µg/ml]
WT MEFs
0
Ube2j1     MEFs
0.8 2.50.30 0.8 2.50.3
XBP1 (unspliced)
XBP1 (spliced)
Tunicamycin [µg/ml]
Figure 3
-/-
Ube2j1     MEFs-/-
Xbp-1
WT
KO
A
18
A0 30 120
B
60
250kDa
25kDa
100kDa
75kDa
Chase time (min)
Chase time (min)
C
IgM
B
22
0
B220
A
A
4.
1
CD1d
C
D
21
CD19
B
22
0
CD23
C
D
21
CD5
C
D
43
Bone
marrow
Spleen
Peritoneal
cavity
B220
AA4.1
CD1d
CD21
CD19
B220
+
+
hi
hi
hi
lo
WT KO
Pre/Pro
27±4
Imm.
9±1
Recirc.
13±3
MZB/MZP
8±6
Mat.
35±7
Imm.
7±2
    FO
72±8
MZB
76±20
MZP
24±20
    B1a
57±8
B2
31±3
   B1
23±1
B1b
44±8
27±2 13±3
7±1
8±2
39±10
10±8
70±6
83±15 17±15
17±5
39±21
50±10
51±10
37kDa
50kDa
150kDa
20kDa
250kDa
25kDa
100kDa
75kDa
37kDa
50kDa
150kDa
20kDa
50kDa
WT KO WT KO
0 30 12060 0 30 12060 0 30 12060
0 30 12060 0 30 12060 0 30 12060 0 30 12060
50kDa
B cell lysate Supernatant
+ Tunicamycin
IP: anti-μ
IP: anti-μ
IP: anti-class I HC
IP: anti-class I HC
WT KO WT KO
B cell lysate Supernatant
Figure 4
19
B C
WT Ube2j1
A
D
E
Motility Morphology
Figure 5
 
WT KO
0
50
100
 
WT KO
0
50
100
  
WT KO
0
1 107
2 107
3 107
4 107
Count
N
um
be
r o
f s
pe
rm *
-/-
20
CD
WT HE
T KO
0.00
0.05
0.10
0.15
Av
er
ag
e 
te
st
is
 w
ei
gh
t i
n 
gr
am
s
Stage
U
be
2j
1
W
T
A
VIII IX
* *
*
*
*
*
*
*
*
*
I II-III IV V VI VII-VIII IX-XI XII
UBE2J1
PNA lectin
DNA
Ube2j1Wild type
II-III
UBE2J1
DDX4
DNA
B
Stage
Figure 6
-/-
-/-
n.s.
n.s.n.s.
21
Figure 7
ES
ES
ES
*
*
*
*
* *
*
*
B
+/+
C
-/-
H
+/+
G
-/-
F
-/-
E
+/+
D
-/-
A
-/-
22
